ARSTAT Inc

Arstat Pharmaceuticals is a privately held company based in Flemington, New Jersey. The company has six employees and reported $2.5 million in revenue. Arstat Pharmaceuticals focuses on developing transformational products for women's health. Their pipeline includes four drug candidates with proven efficacy and safety. Two of these products are ready for Phase III clinical trials, while the other two are prepared for Phase IIb trials. The company's most notable product is Nuvocept, the first and only oral contraceptive designed specifically for women with overweight and obesity. Nuvocept is protected by several U.S. patents and a European patent. Arstat is also developing PREMRING, a vaginal ring for uterine fibroids and endometriosis, and ENHANTA, a non-hormonal therapy for painful and heavy menstrual periods. For more information, visit Arstat Pharmaceuticals' website at www.arstatinfo.com.